top of page

RESEARCH IN FOCUS

Explore OPRI’s collection of published research on Oral Corticosteroid (OCS) use

PUBLICATIONS DATABASE

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

Respiratory Research

23 September 2016

David Halpin, Marjan Kerkhof, Joan B. Soriano, Helga Mikkelsen, David Price

Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study

PLOS ONE

22 September 2016

David Price, Richard Russell, Rafael Mares, Annie Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H. Chavannes, Janwillem Kocks, Jeffrey W. Stephens, John Haughney

Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: effect of drug, dose, and device

Respiratory Medicine

22 September 2016

P.N. Richard Dekhuijzen, Maria Batsiou, Leif Bjermer, Sinthia Bosnic-Anticevich, Henry Chrystyn, Alberto Papi, Roberto Rodríguez-Roisin, Monica Fletcher, Lucy Wood, Alessandra Cifra, Joan B. Soriano, David Price

Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

Journal of Asthma and Allergy

26 August 2016

David Price, Anna Rigazio, Mary Buatti Small, Thomas J Ferro

Long-acting β-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

Journal of Allergy and Clinical Immunology: In Practice

13 July 2016

Steve Turner, Kathryn Richardson, Clare Murray, Mike Thomas, Elizabeth V Hillyer, Annie Burden, David Price, The Respiratory Effectiveness Group

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease

Heart

5 July 2016

Brian Lipworth, Derek Skinner, Graham Devereux, Victoria Thomas, Joanna Ling Zhi Jie, Jessica Martin, Victoria Carter, David Price

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

NPJ Primary Care Respiratory Medicine

23 June 2016

David Price, Glenis Scadding, Claus Bachert, Hesham Saleh, Shuaib Nasser, Victoria Carter, Julie von Ziegenweidti, Alice MS Durieux, Dermot Ryan

Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population

Journal of Alzheimer’s Disease

22 June 2016

Michael Happich, Noam Y. Kirson, Urvi Desai, Sarah King, Howard G. Birnbaum, Catherine Reed, Mark Belger, Alan Lenox-Smith, David Price

Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

BMC Pulmonary Medicine

17 May 2016

Thys van der Molen, Dirkje Postma, Richard J Martin, Ron M.C. Herings, Jetty A. Overbeek, Victoria Thomas, Cristiana Miglio, Richard Dekhuijzen, Nicolas Roche, Theresa W Guilbert, Elliot Israel, Willem M.C. van Aalderen, Elizabeth V Hillyer, Simon van Rysewyk, David Price

Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler

ERJ Open Research

1 April 2016

David Price, Gene Colice, Elliot Israel, Nicolas Roche, Dirkje Postma, Theresa W Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Vicky Thomas, Richard J Martin

Cost-effectiveness of asthma step-up therapy as an increased dose of extrafine-particle inhaled corticosteroid or add-on long-acting beta2-agonist

Pulmonary Therapy

21 March 2016

Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Paul M Dorinsky, Dirkje Postma, Theresa W Guilbert, Jonathan Grigg, Willem M.C. van Aalderen, Francesca Barion, Elizabeth V Hillyer, Victoria Thomas, Annie Burden, R. Brett McQueen, David Price

Pub Med

Reply [Inhaled corticosteroids for asthma therapy in young children: does aerosol particle size matter?

Journal of Allergy and Clinical Immunology: In Practice

2 March 2016

Willem M.C. van Aalderen, Jonathan Grigg, Theresa W Guilbert, Nicolas Roche, Gene Colice, Dirkje Postma, Elizabeth V Hillyer, David Price

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational

NPJ Primary Care Respiratory Medicine

26 February 2016

Kevin Gruffyd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study

NPJ Primary Care Respiratory Medicine

25 February 2016

Kevin Gruffyd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting

Journal of Asthma

26 January 2016

Janine A.M. Westerik, Victoria Carter, Henry Chrystyn, Annie Burden, Samantha L. Thompson, Dermot Ryan, Kevin Gruffyd-Jones, John Haughney, Nicolas Roche, Federico Lavorini, Alberto Papi, Antonio Infantino, Miguel Román Rodríguez, Sinthia Bosnic-Anticevich, Karin Lisspers, Björn Ställberg, Svein Høegh Henrichsen, Thys van der Molen, Catherine Hutton, David Price

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

Journal of Asthma and Allergy

7 January 2016

David Price, Andrew Wilson, Alison Chisholm, Anna Rigazio, Annie Burden, Michael Thomas, Christine King

Inhaled corticosteroid dose-response on blood eosinophils in asthma – Authors’ reply

The Lancet Respiratory Medicine

1 January 2016

David Price, Ian Pavord, Mike Thomas, Christopher J Corrigan, Andrew Wilson, Elizabeth V Hillyer, Marjan Kerkhof

Concept review of dry powder inhalers: correct interpretation of published data

Multidisciplinary Respiratory Medicine

2 December 2015

David Price, Henry Chrystyn

Predicting frequent COPD exacerbations using primary care data

International Journal of Chronic Obstructive Pulmonary Disease

9 November 2015

Marjan Kerkhof, Daryl Freeman, Rupert Jones, Alison Chisholm, David Price, The Respiratory Effectiveness Group

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study

The Lancet Respiratory Medicine

19 October 2015

David Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew Wilson, Mary Buatti Small, Gokul Gopalan, Valerie L Ashton, Annie Burden, Elizabeth V Hillyer, Marjan Kerkhof, Ian Pavord

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
Follow Us
Contact Us
Email: 
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
OPRI Singapore
22 Sin Ming Lane #06-76, Midview City 573969
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
  • Instagram
  • Threads
  • LinkedIn
  • X
Scientist Supplier
OPRI 2025 All Rights Reserved
bottom of page